Indian Regulators Take Steps to Ease Approval Burden for Clinical Trials

International Pharmaceutical Regulatory Monitor
A A
India’s Central Drugs Standard Control Organization has unveiled three new guidelines that it says paves the way forward for more clinical trials in the country by reducing red tape for clinical research.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor